Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chembio Diagnostics Inc (NASDAQ:CEMI)

6.15
Delayed Data
As of Aug 18
 +0.10 / +1.65%
Today’s Change
5.05
Today|||52-Week Range
7.47
-9.56%
Year-to-Date
No recent news for Chembio Diagnostics Inc.

Today’s Trading

Previous close6.05
Today’s open6.00
Day’s range5.84 - 6.15
Volume31,251
Average volume (3 months)23,497
Market cap$75.7M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+59.13%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-26.33%
P/E ratioNM
Price/Sales4.04
Price/Book4.31

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.01+0.88%
ARQLArQule Inc-0.02-1.90%
MRNSMarinus Pharmaceutic...-0.11-3.81%
NBYNovaBay Pharmaceutic...+0.08+1.62%
Data as of 7:59pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$17.9M
Annual profit (last year)-$13.3M
Net profit margin-74.69%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO &
President-Americas Region
Sharon Klugewicz
Vice President-
Operations
David Gyorke
Corporate headquarters
Medford, New York

Forecasts